Activities per year
Activities
- 20 results
Search results
-
Cognitieve problemen na een oncologische behandeling
Nathalie Vanlaer (Speaker)
18 Mar 2025Activity: Talk or presentation › Talk at a public lecture/debate
-
Vorming: omgaan met aandachts- en geheugenproblemen bij kanker (chemobrein)
Nathalie Vanlaer (Speaker)
6 Feb 2025Activity: Talk or presentation › Talk at a public lecture/debate
-
Infosessie geheugen- en aandachtsproblemen
Nathalie Vanlaer (Speaker)
17 Oct 2024Activity: Talk or presentation › Talk at a public lecture/debate
-
Infosessie vezelrijke voeding voor patiënten (Dag Tegen Kanker)
Marthe Verhaert (Speaker)
17 Oct 2024Activity: Talk or presentation › Talk at a public lecture/debate
-
Melanoma treatment Anno 2024
Iris Dirven (Speaker)
9 Mar 2024Activity: Talk or presentation › Talk at a public lecture/debate
-
Wat zijn cognitieve problemen na een kankerbehandeling en wat kan je eraan doen?
Nathalie Vanlaer (Speaker)
19 Oct 2023Activity: Talk or presentation › Talk at a public lecture/debate
-
New Faces of Cancer
Lore Decoster (Invited speaker)
25 May 2023Activity: Talk or presentation › Talk at a public lecture/debate
-
Psychosocial and cognitive complaints after immunotherapy
Nathalie Vanlaer (Speaker)
29 Jan 2023Activity: Talk or presentation › Talk at a public lecture/debate
-
Donateursontmoeting Kom Op Tegen Kanker
Manon Vounckx (Speaker) & Iris Dirven (Speaker)
13 Oct 2023Activity: Talk or presentation › Talk at a public lecture/debate
-
“Feiten & cijfers over innovatie in kankerbehandelingen”
Lore Decoster (Invited speaker)
25 May 2023Activity: Talk or presentation › Talk at a public lecture/debate
-
Lab Secrets for Stratification and Prognoses of Leukemia and Multiple Myeloma using Next-Generation Sequencing (NGS): Strategies to Leverage NGS-based minimal residual disease (MRD) in Multiple Myeloma (MM) and Acute Lymphoblastic Leukemia (ALL)
Wouter De Brouwer (Invited speaker), Jona Van der Straeten (Contributor), Ivan Van Riet (Contributor) & Marleen Bakkus (Contributor)
24 Feb 2022Activity: Talk or presentation › Talk at a public lecture/debate
-
A phase Ib/II clinical trial on intratumoral autologous myeloid dendritic cell therapy in combination with AS01B adjuvant and immune-checkpoint blockade
Jens Tijtgat (Speaker)
19 May 2022Activity: Talk or presentation › Talk at a public lecture/debate
-
Cognitive (dys)functions
Nathalie Vanlaer (Speaker) & Anne Rogiers (Speaker)
17 Mar 2022Activity: Talk or presentation › Talk at a public lecture/debate
-
Medical Meeting - AE management in immunotherapy combination
Sandrine Aspeslagh (Speaker)
27 May 2021Activity: Talk or presentation › Talk at a public lecture/debate
-
Antithrombin: Why and how to look for deficiencies?
Kristin Jochmans (Speaker)
21 Apr 2016Activity: Talk or presentation › Talk at a public lecture/debate
-
A novel FGA mutation underlying a case of congenital dysfibrinogenemia with usual clinical presentation.
Kristin Jochmans (Contributor)
19 Nov 2015Activity: Talk or presentation › Talk at a public lecture/debate
-
Hemostasis in critical care
Kristin Jochmans (Speaker)
4 Apr 2014Activity: Talk or presentation › Talk at a public lecture/debate
-
Thromboprophylaxis in the surgical setting.
Kristin Jochmans (Speaker)
10 Mar 2014Activity: Talk or presentation › Talk at a public lecture/debate
-
WHO classificatie leukemie
Marc De Waele (Speaker)
26 Oct 2010Activity: Talk or presentation › Talk at a public lecture/debate
-
HLA-G IN PREGNANCY
Martine Vercammen (Speaker)
30 Jul 2009Activity: Talk or presentation › Talk at a public lecture/debate